Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Imfinzi Approved in the US as First and Only Immunotherapy Regimen for Patients with Limited-Stage Small Cell Lung Cancer

AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC)...

FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage...

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

 Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

Many Women With Epilepsy Unaware of Seizure Meds' Risks to Pregnancy

Many women with epilepsy who are of childbearing age might not realize their anti-seizure drugs can raise the risk of birth defects or dampen the effectiveness...

Radiation-Free Screening Can ID Interstitial Lung Involvement in RA

For asymptomatic rheumatoid arthritis (RA) patients, a new radiation-free screening protocol can identify suspected interstitial lung involvement (ILI),...

U-Shaped Association Seen for Alcohol Consumption, Cardiometabolic Disease

There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association,...

Endoscopic Full-Thickness Plication Efficacious for GERD

Endoscopic full-thickness plication (EFTP), which improves the valvular mechanism of the gastroesophageal junction, is efficacious for managing gastroesophageal...

Risk for Meniere Disease Higher in Patients With Atopic Dermatitis

The prevalence of Meniere disease is higher in people with atopic dermatitis (AD), according to a study published online Nov. 12 in The Laryngoscope.Cha...

Insurer Anthem Rescinds Anesthesia Policy Change After Backlash

After facing weeks of pushback, health insurer Anthem Blue Cross Blue Shield said Thursday it will not go ahead with a policy change that would have limited...

Analysis Predicts Big Drop for U.S. in Global Health Rankings

Americans are falling farther behind the rest of the developed world when it comes to health and life expectancy, a new study shows.Life expectancy in...

1 in 20 Pregnant U.S. Women Face Emotional, Physical Abuse

Pregnancy can be a trying time for women at best, but new research shows that 1 in every 20 pregnant American women also suffer physical, sexual or emotional...

Phanes Therapeutics’ PT217 Granted Fast Track Designation by the FDA for NEPC

SAN DIEGO, Dec. 4, 2024 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery...

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

(BUSINESS WIRE) December 04, 2024 -- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the...

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug...

Smoker or Former Smoker? Here Are 4 Key Things You Need to Know

MONDAY, Dec.2, 2024 — Doctors have potent new weapons against the deadliest cancer in America and they want to make sure they're on the radar of...

Monthly News Roundup - November 2024

Bimzelx Indications Expanded to Include Hidradenitis Suppurativa, a Debilitating Skin Condition UCB’s Bimzelx (bimekizumab-bkzx) has been granted...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi, Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Bizengri Bizengri (zenocutuzumab-zbco) is a bispecific HER2- and HER3-directed antibody for the treatment of patients with neuregulin 1 fusion...
  • Yesintek Yesintek (ustekinumab-kfce) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
  • Rapiblyk Rapiblyk (landiolol) is an ultra-short acting cardioselective beta-1 adrenergic blocker for for the short-term reduction of ventricular...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development